Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T1101 |
Minocycline hydrochloride
Minocycline HCl,盐酸米诺环素,美满霉素 |
HIF/HIF Prolyl-Hydroxylase; Antibacterial; Antibiotic | Chromatin/Epigenetic; Metabolism; Microbiology/Virology |
Minocycline hydrochloride (Minocycline HCl) 是四环素抗生素,具有出色的吸收和组织渗透性,可用于多种细菌感染以及痤疮的治疗。米诺环素可导致在开始治疗后 1 至 3 个月内发生的急性肝炎样综合征或通常在长期治疗后具有自身免疫特征的更隐匿的慢性肝炎。 | |||
T37746 |
N-phenylacetyl-L-Homoserine lactone
|
Others | Others |
N-phenylacetyl-L-Homoserine lactone 可衰减病原体鲍曼不动杆菌的群体感应,可用于研究细菌感染。 | |||
T11125 |
Durlobactam sodium salt
杜巴坦,ETX2514 sodium salt,杜洛巴坦 |
Antibacterial | Microbiology/Virology |
Durlobactam sodium salt (ETX2514 sodium salt)是一种 β-内酰胺酶抑制剂,针对 A 类 KPC-2、C 类 AmpC 和 D 类 OXA-24,IC50 值分别为 4 nM、14 nM 和 190 nM。 Durlobactam sodium salt 可用于对包括鲍曼不动杆菌在内的耐药革兰氏阴性菌的研究。 | |||
T1569 |
Tigecycline
替加环素,GAR-936 |
ribosome; Antibacterial; Antibiotic; Autophagy | Autophagy; Microbiology/Virology |
Tigecycline (GAR-936) 是甘氨酰环素抗生素,对 Acinetobacter baumannii(A. baumannii) 的 MIC50和 MIC90分别为 1 和 2 mg/L。它对 E. coli(MG1655 菌株) 的平均抑制浓度 (MIC) 约 125 ng/ mL。 | |||
T14492 | BAL-30072 | Others | Others |
BAL30072 shows MIC90 values of 4 μg/mL for MDR Acinetobacter spp. and 8 μg/mL for MDR P. aeruginosa, respectively[1][2]. BAL-30072, a siderophore sulfactam, is a monocyclic beta-lactam antibiotic, with activity against multiresistant gram-negative bacilli | |||
T39983 | SPR206 acetate | ||
SPR206 acetate is a polymyxin analog that exhibits antibiotic activity against Gram-negative pathogens, including multidrug-resistant (MDR) variants. By interacting with the outer membrane of the bacterium, SPR206 acetate effectively combats bacterial infections. Notably, SPR206 acetate demonstrates significant efficacy with minimum inhibitory concentration (MIC) values of 0.125 mg/L against Pseudomonas aeruginosa Pa14 and Acinetobacter baumannii NCTC13301. | |||
T68438 | APO-6619 | ||
APO-6619 is an iron chelator which was shown to inhibit growth of the following bacterial strains: Acinetobacter baumannii, Pseudomonas aeruginosa, Staphylococcus aureus, Klebsiella pneumoniae, and Escherichia coli. APO-6619 may be useful as a non-traditional treatment of bacterial infections. | |||
T61042 |
TBT1
|
||
TBT1 是Acinetobacter 菌株中的 MsbA ATPase 刺激剂和LPS 转运抑制剂。TBT1 以13 μM 的 EC50 值刺激 ATPase 活性。TBT1 是MsbA 转运蛋白的一代抑制剂。 | |||
T39296 | DS86760016 | ||
DS86760016 is a highly effective inhibitor of leucyl-tRNA synthetase (LeuRS), demonstrating potent activity against multidrug-resistant (MDR) Gram-negative bacteria including Escherichia coli, Klebsiella pneumoniae, and Pseudomonas aeruginosa. Notably, DS86760016 effectively inhibits LeuRS enzymes derived from Escherichia coli, Pseudomonas aeruginosa, and Acinetobacter baumannii, exhibiting IC50 values of 0.38 μM, 0.62 μM, and 0.16 μM, respectively. | |||
T75279 | Tigecycline tetramesylate | ||
Tigecycline tetramesylate (GAR-936 tetramesylate)为一款广谱甘氨酰环素类抗生素,对E. coli (MG1655菌株)展现出约125 ng/mL的平均抑制浓度(MIC)。针对Acinetobacter baumannii (A. baumannii)的MIC50与MIC90分别达到1 mg/L与2 mg/L。 | |||
T74866 | Antibacterial agent 116 | ||
Antibacterial agent 116 是一种含二苯甲酮的水杨酰苯胺类化合物。Antibacterial agent 116 能抑制肽聚糖的形成而具有较强的抗菌活性。Antibacterial agent 116 可作为光亲和探针标记 Acinetobacter baumannii 的青霉素结合蛋白 (PBP1b),干扰肽聚糖链的生长,阻断其增殖。 | |||
T74341 | Antibacterial agent 71 | ||
Antibacterial agent 71 (compound 38) 是一种抗生素,同时具有抗革兰氏阴性菌和阳性菌的活性。 | |||
T79240 |
DNA gyrase B-IN-2
|
||
DNA gyrase B-IN-2 (Compound E) 是一款基于2-aminobenzothiazole的DNA gyrase B抑制剂,针对ESKAPE病原体显示出强效活性。该化合物在低纳摩尔浓度下表现出优异的DNA gyrase B抑制能力(IC50< 10 nM),具备对多种ESKAPE病原体的广谱抗菌作用。对于大部分革兰氏阳性菌,最低抑菌浓度(MIC)低于0.03 μg/mL;针对革兰氏阴性病原体如E. coli, Acinetobacter baumannii, Pseudomonas aeruginosa和Klebsiella pneumoniae,MIC为4 - 16 μg/mL。此化合物适用于感染性疾病的研究应用。 | |||
T73798 | Colistin | ||
Colistin (Polymyxin E) 是一种具有口服活性的多肽类抗生素。它对包括多重耐药铜绿假单胞菌、鲍曼不动杆菌和肺炎克雷伯菌在内的多种革兰氏阴性杆菌表现出良好的抑制作用。此外,Colistin 与肾毒性相关,常用于研究革兰氏阴性菌感染。 | |||
T12991 | SPR206 | Others | Others |
SPR206 is a polymyxin analogue and an important class of antibiotic for the treatment of bacterial infections due to multidrug resistant Gram-negative pathogen. |